Attenua, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2015-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.attenua.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)A Dose Escalation Study of Bradanicline in Refractory Chronic Cough
- First Posted Date
- 2018-08-09
- Last Posted Date
- 2019-06-20
- Lead Sponsor
- Attenua, Inc.
- Target Recruit Count
- 46
- Registration Number
- NCT03622216
- Locations
- 🇺🇸
BioSolutions Clinical Research Center, La Mesa, California, United States
🇺🇸Allergy & Asthma Associates of Southern California, Mission Viejo, California, United States
🇺🇸Asthma and Allergy Associates, Colorado Springs, Colorado, United States
News
No news found